{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:27:23Z","timestamp":1786998443177,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Regional Cancer Center of Western Sweden"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.ygyno.2016.05.025","type":"journal-article","created":{"date-parts":[[2016,6,17]],"date-time":"2016-06-17T04:41:20Z","timestamp":1466138480000},"page":"211-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"title":["Centralized primary care of advanced ovarian cancer improves complete cytoreduction and survival - A population-based cohort study"],"prefix":"10.1016","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6699-893X","authenticated-orcid":false,"given":"Pernilla","family":"Dahm-K\u00e4hler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Palmqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Staf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Holmberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liza","family":"Johannesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2016.05.025_bb0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.ygyno.2016.05.025_bb0010","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3802\/jgo.2015.26.4.336","article-title":"Role of aggressive surgical cytoreduction in advanced ovarian cancer","volume":"26","author":"Chang","year":"2015","journal-title":"J. Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2016.05.025_bb0015","doi-asserted-by":"crossref","first-page":"196","DOI":"10.5662\/wjm.v5.i4.196","article-title":"Selecting the best strategy of treatment in newly diagnosed advanced-stage ovarian cancer patients","volume":"5","author":"Minig","year":"2015","journal-title":"World J. Methodol."},{"issue":"4","key":"10.1016\/j.ygyno.2016.05.025_bb0020","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/IGC.0b013e31821b2568","article-title":"2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference","volume":"21","author":"Stuart","year":"2011","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"10","key":"10.1016\/j.ygyno.2016.05.025_bb0025","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"9522","key":"10.1016\/j.ygyno.2016.05.025_bb0030","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/S0140-6736(06)68671-6","article-title":"Surgery for ovarian cancer: how to improve survival","volume":"367","author":"Bristow","year":"2006","journal-title":"Lancet"},{"issue":"10009","key":"10.1016\/j.ygyno.2016.05.025_bb0035","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/S0140-6736(15)01050-8","article-title":"Primary chemotherapy versus primary surgery for ovarian cancer","volume":"386","author":"Scaletta","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ygyno.2016.05.025_bb0040","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ygyno.2013.05.040","article-title":"Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: a meta-analysis","volume":"130","author":"Chang","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2016.05.025_bb0045","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"du Bois","year":"2009","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2016.05.025_bb0050","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ygyno.2011.08.014","article-title":"An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT)","volume":"124","author":"Chi","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2016.05.025_bb0060","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/cncr.22561","article-title":"Centralization of care for patients with advanced-stage ovarian cancer: a cost-effectiveness analysis","volume":"109","author":"Bristow","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2016.05.025_bb0065","article-title":"Is it time to centralize ovarian cancer care in the United States?","author":"Cowan","year":"2015","journal-title":"Ann. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2016.05.025_bb0070","first-page":"499","article-title":"The effect of centralization of primary surgery on survival in ovarian cancer patients","volume":"102","author":"Tingulstad","year":"2003","journal-title":"Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.ygyno.2016.05.025_bb0075","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/cncr.21616","article-title":"Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma","volume":"106","author":"Engelen","year":"2006","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2016.05.025_bb0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ygyno.2014.10.023","article-title":"Ovarian cancer in the United States: contemporary patterns of care associated with improved survival","volume":"136","author":"Cliby","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2016.05.025_bb0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1525-1438.2006.00319.x","article-title":"Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals","volume":"16","author":"Paulsen","year":"2006","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2016.05.025_bb0090","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jamcollsurg.2015.01.056","article-title":"Impact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survival","volume":"220","author":"Bristow","year":"2015","journal-title":"J. Am. Coll. Surg."},{"issue":"4","key":"10.1016\/j.ygyno.2016.05.025_bb0095","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.3747\/co.22.2482","article-title":"The optimal organization of gynecologic oncology services: a systematic review","volume":"22","author":"Fung-Kee-Fung","year":"2015","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.ygyno.2016.05.025_bb0100","article-title":"Integrated care in ovarian cancer \u201cIgV Ovar\u201d: results of a German pilot for higher quality in treatment of ovarian cancer","author":"Keyver-Paik","year":"2015","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2016.05.025_bb0105","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0020-7292(03)90118-4","article-title":"Carcinoma of the ovary","volume":"83","author":"Heintz","year":"2003","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"1","key":"10.1016\/j.ygyno.2016.05.025_bb0110","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/AOG.0000000000000917","article-title":"Oncology FCoG. Staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication of guidelines from the International Federation of Gynecology and Obstetrics (FIGO)","volume":"126","author":"Prat","year":"2015","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2016.05.025_bb0115","first-page":"101","article-title":"The relative survival rate: a statistical methodology","volume":"6","author":"Ederer","year":"1961","journal-title":"Natl. Cancer Inst. Monogr."},{"issue":"4 Suppl","key":"10.1016\/j.ygyno.2016.05.025_bb0120","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/cncr.2820710420","article-title":"Surgical staging and cytoreductive surgery of epithelial ovarian cancer","volume":"71","author":"Hoskins","year":"1993","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2016.05.025_bb0125","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ygyno.2010.05.025","article-title":"The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm","volume":"118","author":"Bristow","year":"2010","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2016.05.025_bb0130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ygyno.2005.07.123","article-title":"Ovarian cancer surgical resectability: relative impact of disease, patient status, and surgeon","volume":"100","author":"Aletti","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2016.05.025_bb0135","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/01.AOG.0000192407.04428.bb","article-title":"Aggressive surgical effort and improved survival in advanced-stage ovarian cancer","volume":"107","author":"Aletti","year":"2006","journal-title":"Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.ygyno.2016.05.025_bb0140","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"issue":"1","key":"10.1016\/j.ygyno.2016.05.025_bb0145","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ygyno.2006.07.045","article-title":"Is time to chemotherapy a determinant of prognosis in advanced-stage ovarian cancer?","volume":"104","author":"Aletti","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2016.05.025_bb0150","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejca.2012.07.023","article-title":"Prognostic impact of the time interval between surgery and chemotherapy in advanced ovarian cancer: analysis of prospective randomised phase III trials","volume":"49","author":"Mahner","year":"2013","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2016.05.025_bb0155","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ygyno.2013.07.086","article-title":"The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma - analysis of patient data in the prospective OVCAD study","volume":"131","author":"Hofstetter","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2016.05.025_bb0160","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ygyno.2010.05.031","article-title":"The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas","volume":"119","author":"Chi","year":"2010","journal-title":"Gynecol. Oncol."},{"issue":"32","key":"10.1016\/j.ygyno.2016.05.025_bb0165","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1200\/JCO.2012.43.2906","article-title":"Failure to rescue as a source of variation in hospital mortality for ovarian cancer","volume":"30","author":"Wright","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2016.05.025_bb0170","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1245\/s10434-012-2673-z","article-title":"Value of tertiary cytoreductive surgery in epithelial ovarian cancer: an international multicenter evaluation","volume":"20","author":"Fotopoulou","year":"2013","journal-title":"Ann. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2016.05.025_bb0175","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ygyno.2009.03.018","article-title":"Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm","volume":"114","author":"Chi","year":"2009","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816307545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816307545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T17:41:31Z","timestamp":1568050891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825816307545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0090825816307545"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.05.025","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Centralized primary care of advanced ovarian cancer improves complete cytoreduction and survival - A population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.05.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}